Overview
- Description
Developer of drugs and proprietary compounds intended to offer new treatments for chronic airway diseases. The company specializes in developing novel and proprietary drugs that preserve the barrier-enhancing effects of azithromycin and uses a non-antibiotic macrolide platform that addresses epithelial dysfunction and other key drivers of inflammation in chronic respiratory diseases, enabling healthcare professionals to provide patients with the right treatment to improve their lives.
- Website
- Country
- Iceland
- Sector
- Health Biotechnology